(Q41179518)

27 September 2017

1 reference

title

Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent (English)

1 reference

27 September 2017

1 reference

1 reference

1 reference

H Fountaine

1

1 reference

27 September 2017

P Harnish

series ordinal

2

1 reference

27 September 2017

E Andrew

series ordinal

3

1 reference

27 September 2017

B Grynne

series ordinal

4

1 reference

27 September 2017

1 September 1996

1 reference

27 September 2017

1 reference

27 September 2017

3 Suppl 3

1 reference

27 September 2017

S475-84

1 reference

Contrast controversy: more to it than meets the eye

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium: an emphasis on European clinical phases I and II

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

The effects of iodixanol and iopamidol on hemodynamic and cardiac electrophysiologic parameters in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Human Pharmacokinetics of Iodixanol

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Iodixanol. Experience in 1,259 patients in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Effects of Coronary Arteriography on Myocardial Blood Flow

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Method for assessing stress-induced regional malperfusion during coronary arteriography. Experimental validation and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

The effect of intracoronary injection of contrast medium upon coronary blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Regional myocardial blood flow during hyperemia induced by contrast agent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Cardiovascular effects of ionic monomeric, ionic dimeric and non-ionic contrast media. Effects in animals on myocardial contractile force, pulmonary and aortic blood pressure and aortic endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Role of Hypertonicity in the Endothelial Injury Caused by Angiographic Contrast Media

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Scanning electron microscopic (SEM) studies on the effect of x-ray contrast media on aortic endothelium in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

The effect of contrast media on the aortic endothelium of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Differential effects of Renografin-76 on the ischemic and nonischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Low-osmolality contrast media in cardiac radiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

The effect of contrast media on the isolated perfused canine heart

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Identification and description of separate mechanisms for two components of renografin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

MYOCARDIAL TOXICITY OF CONTRAST AGENTS USED IN ANGIOGRAPHY

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Hemodynamic and electrocardiographic effects in man of a new nonionic contrast agent (iohexol): advantages over standard ionic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Comparison of meglumine sodium diatrizoate, iopamidol, and iohexol for coronary angiography and ventriculography

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Safety and Cost Effectiveness of High-Osmolality as Compared with Low-Osmolality Contrast Material in Patients Undergoing Cardiac Angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

The effects of coronary injections of iodixanol, iopamidol, and ioxaglate on contractility and electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

The effect of iodixanol, a new isotonic contrast agent, on femoral blood flow in man

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Thromboembolic complications in coronary angiography associated with the use of nonionic contrast medium

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Radiographic contrast agents and platelet function: a quenched-flow study

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Contrast, coagulation, and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Differing mechanisms of clotting inhibition by ionic and nonionic contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Anticoagulant effects of contrast materials: in vitro study of iohexol, ioxaglate, and diatrizoate

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Proteinuria following nephroangiography. III. Role of osmolality and concentration of contrast medium in renal arteries in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

Proteinuria following nephroangiography. VI. Comparison between metrizoate and metrizamide in man

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980362-9

7 January 2021

10.1016/S1076-6332(05)80362-9

Identifiers

DOI

1 reference

27 September 2017

1 reference